KRKG logo

Krka, d. d. Stock Price

LJSE:KRKG Community·€7.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 46 Fair Values set on narratives written by author

KRKG Share Price Performance

€230.00
71.00 (44.65%)
€230.00
71.00 (44.65%)
Price €230.00

KRKG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

0 Risks
4 Rewards

Krka, d. d. Key Details

€2.0b

Revenue

€849.5m

Cost of Revenue

€1.2b

Gross Profit

€760.6m

Other Expenses

€398.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 12, 2026
13.09
57.71%
19.85%
0%
View Full Analysis

About KRKG

Founded
1954
Employees
13107
CEO
Jože Colaric
WebsiteView website
www.krka.biz

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; cerebral and peripheral circulation; vasoprotectives; health care products; and others. In addition, the company offers animal health products comprising antiparasitics, antimicrobials, and other products. Further, the company provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.

Recent KRKG News & Updates

Recent updates

No updates

Krka, d. d. Competitors